Reports for APOTEX INC
Company Name
APOTEX INC
Totals |
||
Shortage reports |
3526 |
|
| Actual shortage: | 229 (6%) | |
| Anticipated shortage: | 3 (0%) | |
| Avoided shortage: | 11 (0%) | |
| Resolved: | 3283 (93%) | |
Discontinuation Reports |
366 |
|
| To be discontinued: | 24 (7%) | |
| Discontinued: | 342 (93%) | |
| Reversed: | 0 (0%) | |
Late reports |
143 (4%) |
|
Overdue reports |
32 (13%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-DICLO | 50MG | TABLET (ENTERIC-COATED) | Resolved | 2023-12-22 | 2024-02-23 | 214238 |
| APO-DICLO | 50MG | TABLET (ENTERIC-COATED) | Resolved | 2024-07-04 | 2024-07-19 | 232306 |
| APO-DICLO RAPIDE 50 MG TABLETS | 50MG | TABLET | Resolved | 2017-10-11 | 2017-11-22 | 25207 |
| APO-DICLO RAPIDE 50 MG TABLETS | 50MG | TABLET | Actual shortage | 2019-11-13 | 2019-11-13 | 98557 |
| APO-DICLO SR | 75MG | TABLET (EXTENDED-RELEASE) | Resolved | 2017-05-24 | 2017-09-22 | 11062 |
| APO-DICLO SR | 75MG | TABLET (EXTENDED-RELEASE) | Resolved | 2017-11-27 | 2018-04-17 | 30805 |
| APO-DICLO SR | 100MG | TABLET (EXTENDED-RELEASE) | Resolved | 2018-07-11 | 2020-01-07 | 55264 |
| APO-DICLO SR | 75MG | TABLET (EXTENDED-RELEASE) | Resolved | 2018-07-11 | 2020-01-07 | 55267 |
| APO-DICLO SR | 75MG | TABLET (EXTENDED-RELEASE) TABLET (EXTENDED-RELEASE) | Resolved | 2021-11-22 | 2021-12-20 | 149705 |
| APO-DICLO SR | 100MG | TABLET (EXTENDED-RELEASE) | Resolved | 2023-12-01 | 2024-01-05 | 212392 |
| APO-DICLO SR | 100MG | TABLET (EXTENDED-RELEASE) | Resolved | 2024-02-09 | 2024-04-19 | 219177 |
| APO-DICLO SR | 75MG | TABLET (EXTENDED-RELEASE) TABLET (EXTENDED-RELEASE) | Resolved | 2024-04-05 | 2024-04-12 | 224580 |
| APO-DICLO SR | 75MG | TABLET (EXTENDED-RELEASE) TABLET (EXTENDED-RELEASE) | Resolved | 2024-07-04 | 2024-08-16 | 232303 |
| APO-DICLO SR | 100MG | TABLET (EXTENDED-RELEASE) | Resolved | 2024-08-01 | 2024-08-16 | 234274 |
| APO-DICLO SR | 75MG | TABLET (EXTENDED-RELEASE) TABLET (EXTENDED-RELEASE) | Resolved | 2024-10-31 | 2024-11-22 | 241685 |
| APO-DICLO SR | 75MG | TABLET (EXTENDED-RELEASE) TABLET (EXTENDED-RELEASE) | Resolved | 2025-09-18 | 2025-10-31 | 267473 |
| APO-DICLO SR | 100MG | TABLET (EXTENDED-RELEASE) | Actual shortage | 2025-12-04 | 2025-12-04 | 273336 |
| APO-DICLOFENAC OPHTHALMIC | 0.1% | SOLUTION | Resolved | 2017-07-25 | 2017-09-22 | 16856 |
| APO-DICLOFENAC OPHTHALMIC | 0.1% | SOLUTION | Resolved | 2019-01-03 | 2019-01-17 | 71121 |
| APO-DICLOFENAC OPHTHALMIC | 0.1% | SOLUTION | Resolved | 2019-10-09 | 2019-11-04 | 95868 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| MELPHALAN FOR INJECTION | 10ML 50MG | POWDER FOR SOLUTION KIT SOLUTION | Discontinued | 2022-03-23 | 2022-03-23 | 157136 |
| NAPROXEN SODIUM TABLETS | 220MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71228 |
| APO-PENTOXIFYLLINE SR | 400MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2018-10-23 | 2022-01-27 | 65438 |
| APO-TEMAZEPAM | 15MG | CAPSULE | Discontinued | 2018-10-23 | 2019-01-14 | 65477 |
| APO-TEMAZEPAM | 30MG | CAPSULE | Discontinued | 2018-10-23 | 2019-01-07 | 65482 |
| TIGECYCLINE | 50MG | POWDER FOR SOLUTION | To be discontinued | 2019-06-21 | 2019-06-21 | 87218 |